Salesh Balak - 27 Feb 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC

Role
Chief Financial Officer
Signature
/s/ Salesh Balak
Issuer symbol
N/A
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 09:30:17 UTC
Previous filing
27 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UBI Common Stock 388,558 27 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBI Stock Option (Right to Buy) Other $0 -216,300 -100% $0.000000* 0 27 Feb 2024 Common Stock 216,300 $0.5000 Direct F1, F3
holding UBI Performance Rights 500,000 27 Feb 2024 Common Stock 500,000 Direct F4
holding UBI Performance Rights 250,000 27 Feb 2024 Common Stock 250,000 Direct F5
holding UBI Stock Option (Right to Buy) 500,000 27 Feb 2024 Common Stock 500,000 $0.3000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is stated in Australian dollars.
F2 The options are fully vested and became exercisable on 03/01/2021.
F3 216,300 stock options vested and became exercisable on 12/31/2017. These options expired on 02/27/2024
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.